 [2007-1-1]Proteasome Inhibition As a Novel Therapeutic Target in Human Cancer |
| [2007-1-1]American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women |
| [2007-1-1]Downregulation of Smac/DIABLO Expression in Renal Cell Carcinoma and Its Prognostic Significance |
| [2007-1-1]Long-Term Survival Rates of Patients With Prostate Cancer in the Prostate-Specific Antigen Screening Era: Population-Based Estimates for the |
| [2007-1-1]Up-Front Tandem High-Dose Chemotherapy Compared With Standard Chemotherapy With Doxorubicin and Paclitaxel in Metastatic Breast Cancer: Resu |
| [2007-1-1]Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling |
| [2007-1-1]Model Describing the Relationship Between Pharmacokinetics and Hematologic Toxicity of the Epirubicin-Docetaxel Regimen in Breast Cancer Pat |
| [2007-1-1]Malignant Breast Tumors After Radiotherapy for a First Cancer During Childhood |
| [2007-1-1]Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730) |
| [2007-1-1]Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials |
| [2007-1-1]Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherap |
| [2007-1-1]Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib |
| [2007-1-1]Wild-Type p53 Overexpression and Its Correlation With MDM2 and p14ARF Alterations: An Alternative Pathway to Non–Small-Cell Lung Cancer |
| [2007-1-1]Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Pha |
| [2007-1-1]Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cel |
| [2007-1-1]Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cel |
| [2007-1-1]Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy |
| [2007-1-1]Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-Trans-Re |
| [2007-1-1]Randomized Phase II Evaluation of 6 g/m2 of Ifosfamide Plus Doxorubicin and Granulocyte Colony-Stimulating Factor (G-CSF) Compared With 12 g |
| [2007-1-1]Status of Surgical Margins and Prognosis in Adult Soft Tissue Sarcomas of the Extremities: A Series of Patients Treated at a Single Institut |
| [2007-1-1]Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial |
| [2007-1-1]Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: |
| [2007-1-1]Detection of Liver Metastases From Endocrine Tumors: A Prospective Comparison of Somatostatin Receptor Scintigraphy, Computed Tomography, an |
| [2007-1-1]Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes |
| [2007-1-1]Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leuke |
| [2007-1-1]Sequencing of Tamoxifen and Radiotherapy After Breast-Conserving Surgery in Early-Stage Breast Cancer |
| [2007-1-1]Sequence of Radiotherapy With Tamoxifen in Conservatively Managed Breast Cancer Does Not Affect Local Relapse Rates |
| [2007-1-1]Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation |
| [2007-1-1]Communicating With Realism and Hope: Incurable Cancer Patients' Views on the Disclosure of Prognosis |
| [2007-1-1]Should 5-Hydroxytryptamine-3 Receptor Antagonists Be Administered Beyond 24 Hours After Chemotherapy to Prevent Delayed Emesis Systematic Re |
| [2007-1-1]Psychoeducational Intervention for Patients With Cutaneous Malignant Melanoma: A Replication Study |
| [2007-1-1]Predictive Value of the Pretreatment Extent of Disease System in Hepatoblastoma: Results From the International Society of Pediatric Oncolog |
| [2007-1-1]Does a History of Childhood Sexual Abuse Affect Sexual Outcomes in Breast Cancer Survivors |
| [2007-1-1]Profile of Patients With Kaposi's Sarcoma in the Era of Highly Active Antiretroviral Therapy |
| [2007-1-1]Molecular Staging in Stage II and III Melanoma Patients and Its Effect on Long-Term Survival |
| [2007-1-1]Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patien |
| [2007-1-1]Selective Excision of Metastatic Brain Tumors Originating in the Motor Cortex With Preservation of Function |
| [2007-1-1]Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Federatio |
| [2007-1-1]Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy With External-Beam Radiation Therapy Alone in Node-Negative |
| [2007-1-1]Randomized Trial of 30 Versus 20 Gy in the Adjuvant Treatment of Stage I Testicular Seminoma: A Report on Medical Research Council Trial TE1 |
| [2007-1-1]First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Pl |
| [2007-1-1]Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study |
| [2007-1-1]Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer Patients |
| [2007-1-1]Concurrent Hyperfractionated Radiotherapy and Low-Dose Daily Carboplatin and Paclitaxel in Patients With Stage III Non–Small-Cell Lung Cance |
| [2007-1-1]Clinical Role of Multidrug Resistance Protein 1 Expression in Chemotherapy Resistance in Early-Stage Breast Cancer: The Austrian Breast and |
| [2007-1-1][18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung Cancer |
| [2007-1-1]Analysis of Concerted Expression of Angiogenic Growth Factors in Acute Myeloid Leukemia: Expression of Angiopoietin-2 Represents an Independ |
| [2007-1-1]Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated |
| [2007-1-1]Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two |
| [2007-1-1]Phase II Trial of Individualized Rituximab Dosing for Patients With CD20-Positive Lymphoproliferative Disorders |
| [2007-1-1]Rituximab Therapy for Patients With Newly Diagnosed, Advanced-Stage, Follicular Grade I Non-Hodgkin's Lymphoma: A Phase II Trial in the Nort |
| [2007-1-1]Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's |
| [2007-1-1]Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer |
| [2007-1-1]Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer |
| [2007-1-1]Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions |
| [2007-1-1]Randomized Pharmacokinetic and Pharmacodynamic Study of Docetaxel: Dosing Based on Body-Surface Area Compared With Individualized Dosing Bas |
| [2007-1-1]Randomized Pharmacokinetic and Pharmacodynamic Study of Docetaxel: Dosing Based on Body-Surface Area Compared With Individualized Dosing Bas |
| [2007-1-1]Randomized Pharmacokinetic and Pharmacodynamic Study of Docetaxel: Dosing Based on Body-Surface Area Compared With Individualized Dosing Bas |
| [2007-1-1]Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Assoc |
| [2007-1-1]Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in |
| [2007-1-1]Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma |
| [2007-1-1]Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of |
| [2007-1-1]Relationship Between MYCN Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar Subtype |
| [2007-1-1]Lymphatic Vessel Invasion As a Prognostic Factor in Patients With Primary Resected Adenocarcinomas of the Esophagogastric Junction |
| [2007-1-1]Molecular and Clinical Analysis of Locally Advanced Dermatofibrosarcoma Protuberans Treated With Imatinib: Imatinib Target Exploration Conso |
| [2007-1-1]EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagno |
| [2007-1-1]Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer |
| [2007-1-1]Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non–Small-Cell Lung Cancer |
| [2007-1-1]Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metasta |
| [2007-1-1]Outcome Predictors for the Increasing PSA State After Definitive External-Beam Radiotherapy for Prostate Cancer |
| [2007-1-1]Individualized Predictions of Disease Progression Following Radiation Therapy for Prostate Cancer |
| [2007-1-1]Evaluation of Tamoxifen and Anastrozole in the Prevention of Gynecomastia and Breast Pain Induced by Bicalutamide Monotherapy of Prostate Ca |
| [2007-1-1]Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D1/Pathologic Node-Positive Adenocarcinoma of the Prostat |
| [2007-1-1]Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast |
| [2007-1-1]Breast Cancer Treatment Guidelines in Older Women |
| [2007-1-1]Changes in Body Fat and Weight After a Breast Cancer Diagnosis: Influence of Demographic, Prognostic, and Lifestyle Factors |
| [2007-1-1]Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without G |
| [2007-1-1]Changes in Body Fat and Weight After a Breast Cancer Diagnosis: Influence of Demographic, Prognostic, and Lifestyle Factors |
| [2007-1-1]Discussions Regarding Reproductive Health for Young Women With Breast Cancer Undergoing Chemotherapy |
| [2007-1-1]Relationship Between Time Interval From Primary Surgery to the Start of Taxane- Plus Platinum-Based Chemotherapy and Clinical Outcome of Pat |
